[1]
Y. Zhou, Y. Chen, C. Ma, B. Shao, and F. Zhang, “Liposomal clodronate combined with Cisplatin or Sorafenib inhibits hepatocellular carcinoma cell proliferation, migration and invasion by suppressing FOXQ1 expression”, Cell Mol Biol (Noisy-le-grand), vol. 66, no. 1, pp. 49–54, Apr. 2020.